FiercePharma6h
Fierce Pharma Asia—Astellas' investment focus; Mitsubishi Tanabe's buyout; Leqembi's 'expansion phase'
Astellas is shifting its investment focus toward more established modalities and later-stage opportunities, its chief ...
Bain to buy Japan's Mitsubishi Tanabe Pharma for $3.4 billion
U.S. private equity firm Bain Capital has bought Mitsubishi Tanabe Pharma in a deal worth 510 billion yen ($3.4 billion), ...
Mitsubishi Reviews Japanese Offshore Wind After Economic Changes
Mitsubishi Corp. is reviewing business plans for three Japanese offshore wind power projects following macroeconomic changes, ...
The Mitsubishi MU-2: A Look At Japan’s Most Successful Post-War Aircraft
Despite production ending in 1986, the aircraft is still flying around today and is popular due to its dependability and ...
Mitsubishi reviews Japan offshore wind projects amid market shifts
Mitsubishi Corp on Monday said it is reviewing how to proceed with its offshore wind projects in Japan given a "significantly ...
Bain Is Said to Near $3 Billion Deal for Mitsubishi Pharma Unit
Bain Capital is nearing a deal to buy Mitsubishi Chemical Group Corp.’s pharmaceutical unit, people familiar with the matter ...